Difference between revisions of "Breast cancer BRCA1 & BRCA2 genetic testing"
Jump to navigation
Jump to search
m (added link) |
Warner-admin (talk | contribs) |
||
Line 19: | Line 19: | ||
==References== | ==References== | ||
<references /> | <references /> | ||
+ | |||
+ | [[Category:Breast cancer pages]] | ||
+ | [[Category:Disease-specific pages]] |
Revision as of 02:19, 24 July 2017
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.
Criteria for BRCA1/BRCA2 genetic testing
This is from a clinical trial protocol and is similar to, but not identical to, the NCCN breast cancer familiar risk assessment guidelines.[1] Additional resources can be found at the links below.[2][3]
- Breast cancer diagnosed ≤45 years old
- Diagnosed at age ≤50 years old with:
- first, second, or third-degree blood relative with breast cancer diagnosis ≤50 years old
- and/or epithelial ovarian or fallopian peritoneal cancer at any age
- Diagnosed at age <60 years old with a triple negative breast cancer
- Two breast primaries--that is, bilateral disease or two or more clearly separate ipsilateral primary tumors--when first breast cancer diagnosis occurred prior to age 50
- Personal history of epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Diagnosed at any age with ≥2 first, second, or third-degree relatives with breast and/or epithelial ovarian, fallopian tube, or primary peritoneal cancer at any age
- First or second-degree relative of anybody known to carry a harmful BRCA1 or BRCA2 mutation
- Ashkenazi Jewish descent
- Male breast cancer
- First, second, or third-degree male relative with breast cancer